Federal Prostate Cancer Research Funding.The charts below compare federal research funding for breast and prostate cancer at theDepartment of Defense (DOD) Prostate Cancer Research Program (PCRP) and at the NationalInstitutes of Health (NIH), primarily at the National Cancer Institute (NCI).

Funding for the DOD PCRP is provided in the Department of Defense Appropriations Bill. Congress directly funds this program annually as part of the Congressionally Directed Medical
Research Program which traditionally includes research funding for breast cancer and ovarian cancer as well.

While Congress also appropriates funding for NIH, funding for specific disease research is determined by the agency. The priorities within NIH and at NCI are not clearly affected by the politics on Capitol Hill. Funding amounts for fiscal years 2008 and 2009 are estimates based on
projected grant requests and current budget projections. Funding for fiscal year 2007 and prior are dollars actually granted.

Despite the statistics, the gap between DOD research funding for prostate cancer and breast cancer continues to widen, and with large increases in fiscal years 2008 and 2009 in the DOD program, the trend continues. The PCRP hit a high funding amount of $100 million in fiscal year 2001, but has not seen that level of funding since then.

DODBreast Cancer Funding (millions of $US) over the past 7 years: 150 150 150 127.5 127.5 138 150
DOD Prostate Cancer (Millions of $US) over the past 5 years:85 85 85 80 80 80 80

Turning now to NIH Research Funding over the last 7 years($ in millions)

Breast Cancer 698.7 ,708, 700, 718, 707, 705, 703 ($ in millions)

Prostate Cancer 398.2 378 373 348 345 344 344 ($ in millions)

Please contact Kevin Johnson, Sr. VicePresident of Public Policy at (202) 487-9455 if you have questions.Sources: National Institutes of Health and the Department of Defense.
DoD Research Funding